Skip to main content
. Author manuscript; available in PMC: 2010 Aug 2.
Published in final edited form as: J Pharmacol Exp Ther. 2008 May 2;326(2):369–379. doi: 10.1124/jpet.108.137208

Fig. 4.

Fig. 4

The PDE2 inhibitor Bay 60-7550 (Bay) and NADPH oxidase inhibitor apocynin reversed the BSO-induced increase in oxidative stress in the amygdala. This was evidenced by a decrease in lipid peroxides (A) and an increase in total antioxidant capacity (B). Values are expressed as means ± S.E.M., n = 4/group. #, p < 0.05 compared with control; *, p < 0.05 compared with BSO-treated group.